{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:53:23Z","timestamp":1790218403560,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.hfc.2021.07.004","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T14:13:01Z","timestamp":1635171181000},"page":"19-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Hypertrophic Cardiomyopathy in RASopathies"],"prefix":"10.1016","volume":"18","author":[{"given":"Michele","family":"Lioncino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Monda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Verrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Moscarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Calcagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Drago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Digilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Putotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Calabr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giovanna","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy E.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Gelb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Limongelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.hfc.2021.07.004_bib1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/ajmg.1320210312","article-title":"Noonan syndrome: A review","volume":"21","author":"Mendez","year":"1985","journal-title":"Am J Med Genet"},{"issue":"12","key":"10.1016\/j.hfc.2021.07.004_bib2","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/eurheartj\/ehy798","article-title":"Clinical presentation and survival of childhood hypertrophic cardiomyopathy: a retrospective study in United Kingdom","volume":"40","author":"Norrish","year":"2019","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.004_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.beem.2010.09.002","article-title":"Noonan syndrome and clinically related disorders","volume":"25","author":"Tartaglia","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.hfc.2021.07.004_bib4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ajhg.2020.06.018","article-title":"Enhanced MAPK1 Function Causes a Neurodevelopmental Disorder within the RASopathy Clinical Spectrum","volume":"107","author":"Motta","year":"2020","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.004_bib5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ajmg.c.10019","article-title":"Costello syndrome: An overview","volume":"117 C","author":"Hennekam","year":"2003","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"4","key":"10.1016\/j.hfc.2021.07.004_bib6","doi-asserted-by":"crossref","first-page":"e1149","DOI":"10.1542\/peds.2013-3189","article-title":"Cardio-facio-cutaneous syndrome: clinical features, diagnosis, and management guidelines","volume":"134","author":"Pierpont","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.hfc.2021.07.004_bib7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijcard.2017.07.068","article-title":"Cardiac defects, morbidity and mortality in patients affected by RASopathies. CARNET study results","volume":"245","author":"Calcagni","year":"2017","journal-title":"Int J Cardiol"},{"issue":"9863","key":"10.1016\/j.hfc.2021.07.004_bib8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0140-6736(12)61023-X","article-title":"Noonan syndrome","volume":"381","author":"Roberts","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2021.07.004_bib9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijcard.2019.06.073","article-title":"Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathy","volume":"299","author":"Limongelli","year":"2020","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.004_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ng1939","article-title":"Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome","volume":"39","author":"Tartaglia","year":"2007","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.hfc.2021.07.004_bib11","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/340847","article-title":"PTPN11 mutations in noonan syndrome: Molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity","volume":"70","author":"Tartaglia","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"7","key":"10.1016\/j.hfc.2021.07.004_bib12","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/humu.21492","article-title":"SOS1 mutations in Noonan syndrome: Molecular spectrum, structural insights on pathogenic effects, and genotype-phenotype correlations","volume":"32","author":"Lepri","year":"2011","journal-title":"Hum Mutat"},{"issue":"11","key":"10.1016\/j.hfc.2021.07.004_bib13","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/humu.22834","article-title":"Activating Mutations Affecting the Dbl Homology Domain of SOS2 Cause Noonan Syndrome","volume":"36","author":"Cordeddu","year":"2015","journal-title":"Hum Mutat"},{"issue":"8","key":"10.1016\/j.hfc.2021.07.004_bib14","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/ng2073","article-title":"Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy","volume":"39","author":"Pandit","year":"2007","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.hfc.2021.07.004_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00439-015-1627-5","article-title":"Spectrum of mutations and genotype\u2013phenotype analysis in Noonan syndrome patients with RIT1 mutations","volume":"135","author":"Yaoita","year":"2016","journal-title":"Hum Genet"},{"issue":"5","key":"10.1016\/j.hfc.2021.07.004_bib16","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/ajmg.a.32206","article-title":"Genotype-phenotype analysis and natural history of left ventricular hypertrophy in LEOPARD syndrome","volume":"146","author":"Limongelli","year":"2008","journal-title":"Am J Med Genet A"},{"issue":"6","key":"10.1016\/j.hfc.2021.07.004_bib17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1017\/S104795110800320X","article-title":"A\u00a0standard echocardiographic and tissue Doppler study of morphological and functional findings in children with hypertrophic cardiomyopathy compared to those with left ventricular hypertrophy in the setting of Noonan and LEOPARD syndromes","volume":"18","author":"Cerrato","year":"2008","journal-title":"Cardiol Young"},{"issue":"3","key":"10.1016\/j.hfc.2021.07.004_bib18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/gim.0b013e31822dd91f","article-title":"Costello syndrome: A Ras\/mitogen activated protein kinase pathway syndrome (rasopathy) resulting from HRAS germline mutations","volume":"14","author":"Gripp","year":"2012","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.004_bib19","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-3-13","article-title":"Leopard syndrome","volume":"3","author":"Sarkozy","year":"2008","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.hfc.2021.07.004_bib20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.hfc.2017.12.005","article-title":"Clinical Presentation and Natural History of Hypertrophic Cardiomyopathy in RASopathies","volume":"14","author":"Calcagni","year":"2018","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.hfc.2021.07.004_bib21","doi-asserted-by":"crossref","first-page":"632293","DOI":"10.3389\/fped.2021.632293","article-title":"Hypertrophic Cardiomyopathy in Children: Pathophysiology, Diagnosis, and Treatment of Non-sarcomeric Causes","volume":"9","author":"Monda","year":"2021","journal-title":"Front Pediatr"},{"issue":"8","key":"10.1016\/j.hfc.2021.07.004_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/genes11080947","article-title":"Combined ptpn11 and mybpc3 gene mutations in an adult patient with noonan syndrome and hypertrophic cardiomyopathy","volume":"11","author":"Caiazza","year":"2020","journal-title":"Genes (Basel)"},{"issue":"S2","key":"10.1016\/j.hfc.2021.07.004_bib23","doi-asserted-by":"crossref","first-page":"S299","DOI":"10.21037\/cdt.2019.05.01","article-title":"Long-term outcomes of childhood onset Noonan compared to sarcomere hypertrophic cardiomyopathy","volume":"9","author":"Kaltenecker","year":"2019","journal-title":"Cardiovasc Diagn Ther"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.004_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ppedcard.2015.01.002","article-title":"Cardiomyopathies in Noonan syndrome and the other RASopathies","volume":"39","author":"Gelb","year":"2015","journal-title":"Prog Pediatr Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2021.07.004_bib25","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ahj.2012.04.018","article-title":"Outcomes in children with Noonan syndrome and hypertrophic cardiomyopathy: A study from the Pediatric Cardiomyopathy Registry","volume":"164","author":"Wilkinson","year":"2012","journal-title":"Am Heart J"},{"issue":"7","key":"10.1016\/j.hfc.2021.07.004_bib26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/archdischild-2013-305047","article-title":"Cardiovascular disease in Noonan syndrome","volume":"99","author":"Prendiville","year":"2014","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.004_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ajmg.c.31765","article-title":"Congenital heart defects in Noonan syndrome: Diagnosis, management, and treatment","volume":"184","author":"Linglart","year":"2020","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"2","key":"10.1016\/j.hfc.2021.07.004_bib28","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/chd.12102","article-title":"Cardiac Findings in Noonan Syndrome on Long-term Follow-up","volume":"9","author":"Colquitt","year":"2014","journal-title":"Congenit Heart Dis"},{"issue":"1 I","key":"10.1016\/j.hfc.2021.07.004_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/01.CIR.65.1.7","article-title":"Hypertrophic cardiomyopathy in infants: Clinical features and natural history","volume":"65","author":"Maron","year":"1982","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.004_bib30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/CIRCULATIONAHA.110.985812","article-title":"Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy","volume":"124","author":"Maron","year":"2011","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.hfc.2021.07.004_bib31","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/bdr2.1670","article-title":"Atypical cardiac defects in patients with RASopathies: Updated data on CARNET study","volume":"112","author":"Calcagni","year":"2020","journal-title":"Birth Defects Res"},{"issue":"12","key":"10.1016\/j.hfc.2021.07.004_bib32","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/BF01958636","article-title":"Noonan syndrome: Structural abnormalities of the mitral valve causing subaortic obstruction","volume":"154","author":"Marino","year":"1995","journal-title":"Eur J Pediatr"},{"issue":"19","key":"10.1016\/j.hfc.2021.07.004_bib33","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/eurheartj\/ehs397","article-title":"Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Rapezzi","year":"2013","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.hfc.2021.07.004_bib34","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/MOP.0000000000000669","article-title":"Cardiovascular disease in Noonan syndrome","volume":"30","author":"Pierpont","year":"2018","journal-title":"Curr Opin Pediatr"},{"issue":"2","key":"10.1016\/j.hfc.2021.07.004_bib35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/adc.2006.104547","article-title":"The natural history of Noonan syndrome: A long-term follow-up study","volume":"92","author":"Shaw","year":"2007","journal-title":"Arch Dis Child"},{"issue":"5","key":"10.1016\/j.hfc.2021.07.004_bib36","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1017\/S1047951117002827","article-title":"Results of balloon pulmonary valvoplasty in children with Noonan\u2019s syndrome","volume":"28","author":"Holzmann","year":"2018","journal-title":"Cardiol Young"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.004_bib37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1442-200X.1996.tb03444.x","article-title":"Cardiovascular abnormalities in Noonan syndrome: The clinical findings and treatments","volume":"38","author":"Ishizawa","year":"1996","journal-title":"Pediatr Int"},{"issue":"5","key":"10.1016\/j.hfc.2021.07.004_bib38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1590\/S0041-87811999000500003","article-title":"Noonan syndrome: a clinical and genetic study of 31 patients","volume":"54","author":"Bertola","year":"1999","journal-title":"Rev Hosp Clin Fac Med Sao Paulo"},{"issue":"6","key":"10.1016\/j.hfc.2021.07.004_bib39","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0022-3476(99)70088-0","article-title":"Congenital heart diseases in children with Noonan syndrome: An expanded cardiac spectrum with high prevalence of atrioventricular canal","volume":"135","author":"Marino","year":"1999","journal-title":"J\u00a0Pediatr"},{"issue":"3","key":"10.1016\/j.hfc.2021.07.004_bib40","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jpeds.2003.11.032","article-title":"Genotype-phenotype correlations in Noonan syndrome","volume":"144","author":"Zenker","year":"2004","journal-title":"J\u00a0Pediatr"},{"issue":"2","key":"10.1016\/j.hfc.2021.07.004_bib41","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ejhg.2012.145","article-title":"Atrioventricular canal defect in patients with RASopathies","volume":"21","author":"Digilio","year":"2013","journal-title":"Eur J Hum Genet"},{"issue":"20","key":"10.1016\/j.hfc.2021.07.004_bib42","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.jacc.2013.06.062","article-title":"Noonan syndrome with complete atrioventricular canal defect with pulmonary stenosis","volume":"62","author":"Pradhan","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.hfc.2021.07.004_bib43","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/ajmg.a.36404","article-title":"Coarctation of the aorta in Noonan-like syndrome with loose anagen hair","volume":"164","author":"Zmolikova","year":"2014","journal-title":"Am J Med Genet Part A"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.004_bib44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF02082326","article-title":"Unusual combination of congenital heart lesions in a child with Noonan\u2019s syndrome","volume":"3","author":"Lam","year":"1982","journal-title":"Pediatr Cardiol"},{"issue":"2","key":"10.1016\/j.hfc.2021.07.004_bib45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s004390050357","article-title":"Noonan syndrome with cardiac left-sided obstructive lesions","volume":"99","author":"Digilio","year":"1997","journal-title":"Hum Genet"},{"issue":"3","key":"10.1016\/j.hfc.2021.07.004_bib46","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/ajmg.a.37505","article-title":"Coronary artery ectasia in Noonan syndrome: Report of an individual with SOS1 mutation and literature review","volume":"170","author":"Calcagni","year":"2016","journal-title":"Am J Med Genet Part A"},{"issue":"13","key":"10.1016\/j.hfc.2021.07.004_bib47","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.jcin.2018.02.041","article-title":"Management of Coronary Artery Aneurysms","volume":"11","author":"Kawsara","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.hfc.2021.07.004_bib48","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/ajmg.a.36982","article-title":"Rapidly progressive hypertrophic cardiomyopathy in an infant with Noonan syndrome with multiple lentigines: Palliative treatment with a rapamycin analog","volume":"167","author":"Hahn","year":"2015","journal-title":"Am J Med Genet Part A"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.004_bib49","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13023-019-1151-0","article-title":"Pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: The multifaceted consequences of PTPN11 mutations","volume":"14","author":"Calcagni","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.hfc.2021.07.004_bib50","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1086\/499925","article-title":"Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease","volume":"78","author":"Tartaglia","year":"2006","journal-title":"Am J Hum Genet"},{"issue":"10","key":"10.1016\/j.hfc.2021.07.004_bib51","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.febslet.2006.03.088","article-title":"Reduced phosphatase activity of SHP-2 in LEOPARD syndrome: Consequences for PI3K binding on Gab1","volume":"580","author":"Hanna","year":"2006","journal-title":"FEBS Lett"},{"issue":"3","key":"10.1016\/j.hfc.2021.07.004_bib52","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/ajmg.a.33857","article-title":"Clinical, pathological, and molecular analyses of cardiovascular abnormalities in Costello syndrome: A Ras\/MAPK pathway syndrome","volume":"155","author":"Lin","year":"2011","journal-title":"Am J Med Genet Part A"},{"key":"10.1016\/j.hfc.2021.07.004_bib53","author":"Gripp"},{"issue":"4","key":"10.1016\/j.hfc.2021.07.004_bib54","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/ajmg.a.33884","article-title":"Phenotypic analysis of individuals with Costello syndrome due to HRAS p.G13C","volume":"155","author":"Gripp","year":"2011","journal-title":"Am J Med Genet Part A"},{"issue":"5","key":"10.1016\/j.hfc.2021.07.004_bib55","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/jmg.2005.040352","article-title":"Genotype-phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases","volume":"43","author":"Kerr","year":"2006","journal-title":"J\u00a0Med Genet"},{"issue":"8","key":"10.1016\/j.hfc.2021.07.004_bib56","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/ajmg.a.38854","article-title":"Nonreentrant atrial tachycardia occurs independently of hypertrophic cardiomyopathy in RASopathy patients","volume":"176","author":"Levin","year":"2018","journal-title":"Am J Med Genet Part A"},{"issue":"9","key":"10.1016\/j.hfc.2021.07.004_bib57","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/ajmg.a.61270","article-title":"Costello syndrome: Clinical phenotype, genotype, and management guidelines","volume":"179","author":"Gripp","year":"2019","journal-title":"Am J Med Genet Part A"},{"issue":"5","key":"10.1016\/j.hfc.2021.07.004_bib58","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/ajmg.a.35292","article-title":"Prevalence and clinical features of Costello syndrome and cardio-facio-cutaneous syndrome in Japan: Findings from a nationwide epidemiological survey","volume":"158 A","author":"Abe","year":"2012","journal-title":"Am J Med Genet Part A"},{"issue":"2","key":"10.1016\/j.hfc.2021.07.004_bib59","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ajmg.c.30295","article-title":"Cardio-facio-cutaneous syndrome: Does genotype predict phenotype?","volume":"157","author":"Allanson","year":"2011","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.004_bib60","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ajmg.10681","article-title":"CFC index for the diagnosis of cardiofaciocutaneous syndrome","volume":"112","author":"Kavamura","year":"2002","journal-title":"Am J Med Genet"},{"issue":"4","key":"10.1016\/j.hfc.2021.07.004_bib61","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/jmg.2007.054460","article-title":"Further delineation of cardio-facio-cutaneous syndrome: Clinical features of 38 individuals with proven mutations","volume":"45","author":"Armour","year":"2008","journal-title":"J\u00a0Med Genet"},{"issue":"3","key":"10.1016\/j.hfc.2021.07.004_bib62","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ajmg.a.10923","article-title":"Noonan-like syndrome with loose anagen hair: A new syndrome?","volume":"118 A","author":"Mazzanti","year":"2003","journal-title":"Am J Med Genet"},{"issue":"2","key":"10.1016\/j.hfc.2021.07.004_bib63","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ajhg.2010.06.015","article-title":"Heterozygous germline mutations in the CBL tumor-suppressor gene cause a noonan syndrome-like phenotype","volume":"87","author":"Martinelli","year":"2010","journal-title":"Am J Hum Genet"},{"issue":"9","key":"10.1016\/j.hfc.2021.07.004_bib64","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/ng.641","article-title":"Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic Leukemia","volume":"42","author":"Niemeyer","year":"2010","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.hfc.2021.07.004_bib65","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/jmg.2010.076836","article-title":"Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia","volume":"47","author":"P\u00e9rez","year":"2010","journal-title":"J\u00a0Med Genet"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.004_bib66","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1442-200X.1996.tb03445.x","article-title":"Hypertrophic cardiomyopathy in Noonan syndrome","volume":"38","author":"Nishikawa","year":"1996","journal-title":"Pediatr Int"},{"issue":"4","key":"10.1016\/j.hfc.2021.07.004_bib67","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ng772","article-title":"Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome","volume":"29","author":"Tartaglia","year":"2001","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.004_bib68","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1749-6632.2010.05790.x","article-title":"Disorders of dysregulated signal traffic through the RAS-MAPK pathway: Phenotypic spectrum and molecular mechanisms","volume":"1214","author":"Tartaglia","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.hfc.2021.07.004_bib69","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1172\/JCI44929","article-title":"MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1L613V mutation","volume":"121","author":"Wu","year":"2011","journal-title":"J\u00a0Clin Invest"},{"issue":"17","key":"10.1016\/j.hfc.2021.07.004_bib70","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.jacc.2019.01.066","article-title":"Hypertrophic Cardiomyopathy in Noonan Syndrome Treated by MEK-Inhibition","volume":"73","author":"Andelfinger","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2021.07.004_bib71","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1172\/JCI44972","article-title":"Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation","volume":"121","author":"Marin","year":"2011","journal-title":"J\u00a0Clin Invest"},{"issue":"3\u20134","key":"10.1016\/j.hfc.2021.07.004_bib72","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10554-005-9034-y","article-title":"Hypertrophic cardiomyopathy in Noonan syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations","volume":"22","author":"Hudsmith","year":"2006","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2021.07.004_bib73","article-title":"2020 AHA\/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy","author":"Ommen","year":"2020","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.hfc.2021.07.004_bib74","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1017\/S1047951119001720","article-title":"Sudden cardiac arrest in the field in an 18-year-old male athlete with Noonan syndrome: Case presentation and 5-year follow-up","volume":"29","author":"Petrin","year":"2019","journal-title":"Cardiol Young"},{"issue":"2","key":"10.1016\/j.hfc.2021.07.004_bib75","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1017\/S1047951110001708","article-title":"Sudden death in a patient with Noonan syndrome","volume":"21","author":"Aydin","year":"2011","journal-title":"Cardiol Young"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.004_bib76","doi-asserted-by":"crossref","DOI":"10.1186\/s13256-019-2096-6","article-title":"Out-of-hospital cardiac arrest and survival in a patient with Noonan syndrome and multiple lentigines: A case report","volume":"13","author":"Eichhorn","year":"2019","journal-title":"J\u00a0Med Case Rep"},{"issue":"3","key":"10.1016\/j.hfc.2021.07.004_bib77","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/CIRCULATIONAHA.120.047235","article-title":"A\u00a0validated model for sudden cardiac death risk prediction in pediatric hypertrophic cardiomyopathy","volume":"142","author":"Miron","year":"2020","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.hfc.2021.07.004_bib78","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jamacardio.2019.2861","article-title":"Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids)","volume":"4","author":"Kaski","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2021.07.004_bib79","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1017\/S1047951100006818","article-title":"Verapamil therapy in infants with hypertrophic cardiomyopathy","volume":"8","author":"Moran","year":"1998","journal-title":"Cardiol Young"},{"issue":"2","key":"10.1016\/j.hfc.2021.07.004_bib80","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/01.CIR.67.2.413","article-title":"Hemodynamic effects of verapamil in children and adolescents with hypertrophic cardiomyopathy","volume":"67","author":"Spicer","year":"1983","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.hfc.2021.07.004_bib81","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.amjcard.2015.06.037","article-title":"Surgical Ventricular Septal Myectomy for Patients with Noonan Syndrome and Symptomatic Left Ventricular Outflow Tract Obstruction","volume":"116","author":"Poterucha","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2021.07.004_bib82","doi-asserted-by":"crossref","DOI":"10.1053\/j.semtcvs.2018.12.004","article-title":"Early Outcomes of Cardiac Surgery in Patients with Noonan Syndrome","author":"Hemmati","year":"2019","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.hfc.2021.07.004_bib83","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13535","article-title":"Cardiac transplantation in children with Noonan syndrome","volume":"23","author":"McCallen","year":"2019","journal-title":"Pediatr Transplant"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.004_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2015.10.023","article-title":"The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update","volume":"35","author":"Mehra","year":"2016","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.hfc.2021.07.004_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2017.07.018","article-title":"The Registry of the International Society for Heart and Lung Transplantation: Twentieth Pediatric Heart Transplantation Report-2017; Focus Theme: Allograft ischemic time","author":"Rossano","year":"2017","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"3","key":"10.1016\/j.hfc.2021.07.004_bib86","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/CIRCHEARTFAILURE.110.959288","article-title":"Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy","volume":"4","author":"Topilsky","year":"2011","journal-title":"Circ Hear Fail"},{"issue":"17","key":"10.1016\/j.hfc.2021.07.004_bib87","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa021715","article-title":"The Incidence of Pediatric Cardiomyopathy in Two Regions of the United States","volume":"348","author":"Lipshultz","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.hfc.2021.07.004_bib88","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/CIRCULATIONAHA.106.621185","article-title":"Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: Findings from the Pediatric Cardiomyopathy Registry","volume":"115","author":"Colan","year":"2007","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.hfc.2021.07.004_bib89","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.healun.2009.05.028","article-title":"Outcomes of Pediatric Patients With Hypertrophic Cardiomyopathy Listed for Transplant","volume":"28","author":"Gajarski","year":"2009","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.hfc.2021.07.004_bib90","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/ajmg.a.61485","article-title":"Advancing RAS\/RASopathy therapies: An NCI-sponsored intramural and extramural collaboration for the study of RASopathies","volume":"182","author":"Gross","year":"2020","journal-title":"Am J Med Genet Part A"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713621000738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713621000738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:42:11Z","timestamp":1761554531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713621000738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1551713621000738"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2021.07.004","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypertrophic Cardiomyopathy in RASopathies","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2021.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}